Quick Answer
Teladoc Health, Inc. reported Diluted EPS of $1.14 per share (loss) for fiscal year 2025.
Teladoc Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.14 | +80.6% |
| 2024 | -$5.87 | -338.1% |
| 2023 | -$1.34 | +98.4% |
| 2022 | -$84.60 | -2998.9% |
| 2021 | -$2.73 | +49.1% |
| 2020 | -$5.36 | -288.4% |
| 2019 | -$1.38 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.28 | -47.4% | -47.4% |
| June 30, 2025 | -$0.19 | +96.1% | +64.2% |
| March 31, 2025 | -$0.53 | -8.2% | -178.9% |
| September 30, 2024 | -$0.19 | +45.7% | +96.1% |
| June 30, 2024 | -$4.92 | -1130.0% | -904.1% |
| March 31, 2024 | -$0.49 | -16.7% | -40.0% |
| September 30, 2023 | -$0.35 | +22.2% | +12.5% |
| June 30, 2023 | -$0.40 | +97.9% | +4.8% |
- Teladoc Health, Inc. showed an increase of +80.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Teladoc Health, Inc.’s diluted eps has grown by 17.4% (from $1.38 per share (loss) to $1.14 per share (loss)).
- The most recent figure is from Teladoc Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: